25.1 C
Jalandhar
Sunday, October 17, 2021

ਵਾਹਿਗੁਰੂ

spot_img
yes punjab punjabi redirection

kissan

ajaib ghar

sarkari naukri

bijli

madadgaar

sports club

kisan sarkari naukri

muavja

Markfed Sept to Nov

mrsptu

Innocent

This drug holds promise for arthritis treatment

- Advertisement -

London, Jan 1, 2020-

Researchers have identified a drug that can significantly reduce bone and cartilage progression in osteoarthritis.

In a study, published in the journal Annals of Internal Medicine, the researchers found that “MIV-711” — a novel selective cathepsin K inhibitor — can reduce disease progression in osteoarthritis.

However, the drug was not more effective than placebo for reducing pain related to knee osteoarthritis.

Osteoarthritis of the knee is a painful, disabling condition affecting more than 14 million people in the US and hundreds of millions worldwide.

The pain of knee osteoarthritis arises from a series of pathologic processes involving articular cartilage, subchondral bone, synovium, meniscus, and other joint structures, ultimately leading to joint failure and pain-related functional limitations.

A team of researchers led by the University of Leeds in UK, sought to test the hypothesis that cathepsin K inhibitor could alleviate osteoarthritis symptoms by reducing degeneration of bone and cartilage.

In a multi-centre study, 244 patients with primary knee osteoarthritis were randomly assigned to receive either 100 or 200 mg daily of MIV-711 or matched placebo for 26 weeks to evaluate the efficacy, safety, and tolerability of MIV-711.

The primary endpoint of the study was change in pain score, but changes in disease progression were also assessed using quantitative MRI outcomes.

The researchers found that compared with placebo, MIV-711 was associated with less bone remodelling, less cartilage volume loss, and lower levels of bone resorption and collagen loss.

However, it showed no beneficial effects on osteoarthritic knee pain.

According to the researchers, further evaluation is needed to confirm the structural benefits of MIV-711 and to determine whether these translate to more tangible benefits on disease symptoms.

The researchers said that while the work is promising, they agree that more research is needed to determine the longer term benefits of MIV-711.  (Agency)

- Advertisement -

Yes Punjab - TOP STORIES

Punjab News

Sikh News

Transfers, Postings, Promotions

- Advertisement -spot_img

Stay Connected

20,369FansLike
112,605FollowersFollow

ENTERTAINMENT

National

GLOBAL

OPINION

Indian Population

In the light of the population explosion debate – by Nirendra Dev

Mizoram has made news -- not necessarily for the wrong reasons but certainly for quite unexpected reasons. North-Eastern India generally makes news due to...
Terrorists Shadow

Tackling the resurgence of jihad in Kashmir – by Amjad Ayub Mirza

With three encounters taking place in less than 24 hours between October 10 and 11, terrorist insurgency has effectively resurged in the Kashmir Valley....
DSGMC Logo

Present Peculiar Scenario of DSGMC post 2021 Elections – by Inder Mohan Singh

The management of the historical Gurdwaras of Delhi came into the hands of local Sikh electorate after enforcement of ‘Delhi Sikh Gurdwaras Act 1971...

SPORTS

Health & Fitness

wearable device uses sweat to monitor glucose level

New wearable device uses sweat to monitor glucose levels

New York, Oct 17, 2021- Dread pricking your fingers every morning to monitor your glucose levels? Take heart, US scientists have developed the prototype of a first-of-its-kind wearable glucose monitoring device that uses sweat on skin instead of needles.A team from the Pennsylvania State University constructed the device first with laser-induced graphene (LIG) -- a material consisting of atom-thick...

Gadgets & Tech